CAPRELSA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Genzyme Corporation. The primary component is Vandetanib.
| Product ID | 58468-7840_1b138df2-ee22-47e9-aa69-06445ff56eed |
| NDC | 58468-7840 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CAPRELSA |
| Generic Name | Vandetanib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-07-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022405 |
| Labeler Name | Genzyme Corporation |
| Substance Name | VANDETANIB |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2011-07-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022405 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-07-25 |
| Ingredient | Strength |
|---|---|
| VANDETANIB | 300 mg/1 |
| SPL SET ID: | e5721cb8-4185-47b9-bbb3-1c587e558a03 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-7820 | CAPRELSA | Vandetanib |
| 0310-7840 | CAPRELSA | Vandetanib |
| 58468-7820 | CAPRELSA | Vandetanib |
| 58468-7840 | CAPRELSA | Vandetanib |
| 58468-7860 | CAPRELSA | Vandetanib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CAPRELSA 85360880 4211262 Live/Registered |
GENZYME CORPORATION 2011-06-30 |
![]() CAPRELSA 78588611 3092679 Live/Registered |
GENZYME CORPORATION 2005-03-16 |